TABLE 2.
Baseline clinical characteristics of the patients in non‐intravenous thrombolysis (IVT) group.
| Total (n = 114) | Good outcome mRS (n = 46) | Poor outcome mRS (2–6) (n = 68) | p‐Value | |
|---|---|---|---|---|
| Characteristics mean ± SD/N (%) | ||||
| Age, years | 69.72 ± 11.67 | 68.3 ± 12.21 | 70.68 ± 11.29 | .30 |
| Sex | 61 (53.51%) | 29 (63.04%) | 32 (47.06%) | .14 |
| Vascular risk factors, N (%) | ||||
| Hypertension | 87 (76.32%) | 32 (69.57%) | 55 (80.88%) | .24 |
| Diabetes mellitus | 32 (28.07%) | 5 (10.87%) | 27 (39.71%) | .00 |
| Active smokers | 37 (32.46%) | 19 (41.30%) | 18 (26.47%) | .15 |
| Drink | 30 (26.32%) | 17 (36.96%) | 13 (19.12%) | .06 |
| History of CI | 13 (11.40%) | 4 (8.70%) | 9 (13.24%) | .56 |
| History of CH | 2 (1.75%) | 1 (2.17%) | 1 (1.47%) | 1.00 |
| Atrial fibrillation | 32 (28.07%) | 14 (30.43%) | 18 (26.47%) | .80 |
| Myocardial infarct | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | .04 |
| NIHSS | 5 (3, 7) | 3 (2, 5) | 6 (4, 9) | .00 |
| WBCd1 | 6.88 (5.26, 8.11) | 6.42 (5.1, 7.88) | 7.01 (5.69, 8.3) | .18 |
| WBCd3 | 6.64 (5.46, 8.12) | 5.97 (4.97, 7.36) | 7.04 (5.69, 8.76) | .02 |
| WBCd7 | 6.38 ± 1.87 | 5.96 ± 1.71 | 6.67 ± 1.92 | .04 |
| Neutrophil counts (109/L) d1 | 4.87 (3.44, 6.09) | 4.14 (3.37, 5.55) | 5.18 (3.72, 6.56) | .02 |
| Neutrophil counts (109/L) d3 | 4.28 (3.53, 5.96) | 3.86 (3.17, 4.69) | 4.89 (3.79, 6.55) | .00 |
| Neutrophil counts (109/L) d7 | 3.99 (2.92, 5.09) | 3.47 (2.54, 4.29) | 4.28 (3.36, 5.38) | .00 |
| Lymphocyte counts (109/L) d1 | 1.45 (1.05, 1.79) | 1.65 (1.25, 1.92) | 1.34 (0.98, 1.67) | .02 |
| Lymphocyte counts (109/L) d3 | 1.47 (1.17, 1.88) | 1.54 (1.21, 1.91) | 1.45 (1.15, 1.84) | .54 |
| Lymphocyte counts (109/L) d7 | 1.54 (1.24, 1.81) | 1.61 (1.35, 2) | 1.46 (1.22, 1.75) | .06 |
| NLR d1 | 3.43 (2.15, 5.11) | 2.5 (2, 3.97) | 4.09 (2.64, 5.9) | .00 |
| NLR d3 | 2.91 (2.22, 4.09) | 2.46 (1.92, 3.27) | 3.21 (2.49, 4.72) | .00 |
| NLR d7 | 2.68 (1.91, 3.77) | 2.05 (1.5, 3.07) | 3 (2.28, 4.07) | .00 |
Abbreviations: CI, confidence intervals; mRS, modified Rankin scale; NIHSS, National Institutes of Health Stroke Scale; NLR, neutrophil‐to‐lymphocyte ratio.